SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

Biocryst Pharmaceuticals is seeing significant market activity and heightened community discourse driven by persistent acquisition rumors and notable institutional volume in after-hours trading. Traders are actively debating the stock's valuation relative to its rare disease pipeline, while observing unconventional trading patterns that have fueled speculation of a potential buyout.

Grayscale Bitcoin Mini Trust ETF - Common units of fractional undivided beneficial interest

Grayscale Bitcoin Mini Trust ETF

The Grayscale Bitcoin Mini Trust ETF is trending as investors grapple with heightened market volatility driven by escalating geopolitical tensions and institutional debates over Bitcoin's long-term utility as a hedge. The community remains deeply divided, with bulls pointing to historical price cycles and potential regulatory breakthroughs like the Clarity Act, while bears are emphasizing downside risks linked to broader economic uncertainty and shifting institutional flow dynamics.

Block, Inc. engages in creating ecosystems for distinct customer audiences. It operates through the Square and Cash App segments. The Square segment provides payment services, software solutions, hardware, and financial services to sellers. The Cash App segment includes the financial tools available to individuals within the mobile Cash App, including peer-to-peer payments, bitcoin and stock investments. It also includes Cash App Card, which is linked to customer stored balances that customers can use to pay for purchases or withdraw funds from an ATM. The company was founded by Jack Patrick Dorsey and James Morgan McKelvey in February 2009 and is headquartered in Oakland, CA.

Block Inc - Ordinary Shares - Class A

Block Inc

Block Inc. is seeing significant investor attention following a massive workforce reduction and strategic pivot toward an AI-native operational model, which triggered a strong positive market reaction despite broader fintech sector volatility. The community is actively debating the long-term implications of these aggressive cost-cutting measures, weighing the boost to profitability against concerns over potential brand impact and the sustainability of AI-driven restructuring.

Pyth Network is a decentralised oracle network designed to provide real-time financial market data to decentralised applications (dApps) across multiple blockchains. It allows developer to secure smart contracts with reliable, low-latency market data from institutional sources, and build apps with high-fidelity oracle feeds designed for mission-critical systems.

Pyth Network

Pyth Network is capturing market attention as essential DeFi infrastructure, bolstered by a high-profile partnership with the U.S. Department of Commerce to provide macroeconomic data on-chain. Investors are actively discussing the project's institutional-grade data model, its revenue-generating potential through protocol buybacks, and its critical role in the expanding Real World Asset (RWA) narrative.

Sharplink, Inc. is an institutional-grade Ethereum treasury platform that provides public market investors with exposure to ETH. The platform focuses on Ethereum, which is used in various stablecoin, tokenized real-world asset, and decentralized finance settlement applications. This allows for native yield generation and potential network growth opportunities with ETH. The company is also involved in the online affiliate marketing business. The company was founded in 2019 and is headquartered in Miami, FL.

Sharplink Inc.

SharpLink Gaming Ltd

SharpLink Gaming is under intense scrutiny as shareholders react to the termination of a material asset management agreement, fueling widespread debate over the company's long-term viability and crypto-treasury strategy. The community is heavily polarized, with vocal investors expressing extreme frustration over persistent share price dilution and underperformance while others remain optimistic, citing the company's significant Ethereum holdings and staking yield as a deep-value opportunity.

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: Dupixent, Evkeeza, Eylea, Inmazeb, and Kevzara. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, George Damis Yancopoulos, and Eric M. Shooter on January 8, 1988, and is headquartered in Tarrytown, NY.

Regeneron Pharmaceuticals, Inc.

Regeneron Pharmaceuticals (REGN) is currently seeing heightened trading activity as investors react to regulatory challenges at a third-party manufacturing facility, which has triggered delays for key products like Eylea HD. While sentiment remains divided due to these supply chain hurdles and competitive pressure in the ophthalmology space, the community is closely monitoring upcoming earnings and pipeline developments, with many bulls pointing to strong revenue growth from blockbusters like Dupixent and Libtayo as reasons for long-term optimism.

Arista Networks, Inc. engages in the development, marketing, and sale of cloud networking solutions. Its solutions include EOS, a set of network applications, and Gigabit Ethernet switching and routing platforms. Its product categories include Core, Cognitive Adjacencies, and Network Software and Services. The company was founded by Andreas Bechtolsheim, David Cheriton, and Kenneth Duda in November 2004 and is headquartered in Santa Clara, CA.

Arista Networks Inc

Arista Networks is currently trending due to intense volatility following a quarterly earnings report that featured a strong double beat on top and bottom lines but provided cautious forward revenue guidance. The community is actively debating whether the double-digit price decline is a baseless overreaction caused by market makers or a justified correction given the stock's high valuation and competitive concerns within the AI infrastructure sector.

Transocean Ltd. engages in the provision of offshore contract drilling services for oil and gas wells. It also owns and operates offshore drilling fleets such as ultra-deepwater, harsh environment, deepwater, and midwater rigs. The company was founded in 1953 and is headquartered in Steinhausen, Switzerland.

Transocean Ltd

Transocean (RIG) is currently capturing significant attention as investors react to the company's $5.8 billion all-stock merger with Valaris, which positions the combined entity as a dominant force in offshore drilling. The stock is being buoyed by a tightening high-specification drillship market, rising day rates, and ongoing geopolitical tensions in the Middle East that keep energy supply security at the forefront of community discussions.

Global X Funds - Global X Dow 30 Covered Call ETF

Global X Dow 30 Covered Call ETF

The DJIA is currently oscillating amidst a complex landscape of geopolitical tension, cooling energy prices, and mixed economic data that have investors scrutinizing the sustainability of recent market highs. Market participants remain focused on potential Fed policy shifts and the impact of upcoming earnings cycles, while community discussions continue to center on how prolonged global instability could influence corporate valuation multiples.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizer is trending as investors weigh the potential impact of looming pharmaceutical tariffs, which are pushing the company to increase its U.S. manufacturing footprint. Simultaneously, the community is actively debating the company's aggressive M&A strategy, particularly its focus on expanding oncology and T-cell engager therapy pipelines, while keeping a watchful eye on patent litigation risks.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>Barclays analyst Tom O'Malley raised the firm's price target on Arm to $200 from $165 and kept an ‘Overweight’ rating on the shares.</li><li>RBC Capital said that Arm’s much-anticipated full-chip strategy will complement its IP business.</li><li>Arm on Tuesday had announced that it is extending into&nbsp;the&nbsp;production of silicon products for the first time in its history.&nbsp;</li></ul>Shares of Arm Holdings (ARM) closed 16% higher on Wednesday as several analysts were buoyed by the company's outlook as well as its first company-designed data center CPU.&nbsp;Arm on Tuesday had announced that it is extending into&nbsp;the production of silicon products for the first time in its history with the launch of the Arm AGI CPU, an Arm-designed CPU for AI data centers, built to address a rising class of agentic AI workloads.Arm CEO Rene Haas reportedly told Bloomberg in an interview on Tuesday that the company expects its own chips business to generate about $15 billion in annual sales in five years. Meta Platforms (META) will be the first major customer for the company's new AGI CPU chip.<h2 class="st-heading-2">Bullish Wall Street</h2>Raymond James&nbsp;subsequently upgraded Arm to ‘Outperform’ from ‘Market Perform’ with a $166 price target. The firm cited the company's announced business model shift to include a fabless semiconductor element for the upgrade, per TheFly.&nbsp;Barclays analyst Tom O'Malley raised the firm's price target on Arm to $200 from $165 and kept an ‘Overweight’ rating on the shares. The "Arm Everywhere" event made it clear that CPUs play a very important role in agentic AI and the company's solution is the AGI CPU, which "plays to ARM's strength in energy efficiency," the analyst told investors.RBC Capital also raised the firm's price target on Arm to $175 from $130 and kept an ‘Outperform’ rating on the shares. The firm cited the company's much-anticipated full-chip strategy, which the management believes will complement its IP business, the analyst told investors in a research note. The strategy offers significant revenue growth and earnings potential over the long term but comes with gross margin dilution and channel conflict issues, RBC Capital added.<h2 class="st-heading-2">Retail Reaction</h2>Retail sentiment around ARM trended in ‘extremely bullish’ territory amid ‘extremely high’ message volume.&nbsp;Shares in the company have risen 39% so far in 2026.&nbsp;

The replica of the ARM is an electronic chip board during a collaborative ceremony launching a partnership between Malaysia and ARM Holdings in Kuala Lumpur, Malaysia, on March 5, 2025. 

Why Did Arm Stock Close 16% Higher Today?

Raymond James upgraded Arm to ‘Outperform’ from ‘Market Perform’ with a $166 price target. The firm cited the company's business model shift to include a fabless semiconductor element for the upgrade.

Equity

Raymond James upgraded Arm to ‘Outperform’ from ‘Market Perform’ with a $166 price target. The firm cited the company's business model shift to include a fabless semiconductor element for the upgrade.


Is First Trust NASDAQ-100-Technology Sector ETF (QTEC) a Strong ETF Right Now?

Should You Invest in the First Trust NASDAQ-100-Technology Sector ETF (QTEC)?

Worried About Oracle's Downfall? Hedge With These 5 Top-Ranked Tech ETFs

Oracle's selloff, tied to AI spending and debt fears, has rattled investors. Diversifying with top tech ETFs like XLK could help mitigate single-stock risk.

MongoDB (MDB) shares tumbled as much as 19% in pre-market trade on Thursday after issuing underwhelming guidance for fiscal 2026, triggering a downgrade from Wells Fargo and a wave of price target cuts across Wall Street.The database software company&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/mongodb-plummets-aftermarket-as-guidance-misses-estimates/cheFYBNR68">reported</a> fourth-quarter (Q4) earnings per share (EPS) of $1.28, nearly doubling analysts’ expectations of $0.66.&nbsp;Revenue came in at $548.4 million, exceeding estimates of $519.84 million.Despite the strong results, Wall Street seems rattled by MongoDB’s outlook.&nbsp;The company projected fiscal 2026 revenue between $2.24 billion and $2.28 billion, falling short of the consensus estimate of $2.32 billion.&nbsp;Earnings guidance&nbsp;is forecast between&nbsp;$2.44 and $2.62, well below Wall Street’s estimate of $3.39.Wells Fargo downgraded the stock to ‘Equal Weight’ from ‘Overweight’ and slashed its price target by more than $100 to $225 from $365.The brokerage noted that MongoDB’s guidance and slowing multi-year deals suggest a challenging fiscal 2026.&nbsp;Wells Fargo views the upcoming year as a “transition period” for the company, warning that revenue growth will “significantly decelerate” and limit the stock’s upside.It added that MongoDB is still in the early stages of monetization, with Atlas starting to see further stabilization in its note to investors.&nbsp;Atlas revenue contributed to 68% of MongoDB's topline and climbed 32.6% year-over-year, outpacing overall company growth.Other major firms, including Barclays, Bank of America, Morgan Stanley, and Piper Sandler, maintained their ‘Buy’-equivalent ratings but reduced their price targets,&nbsp;citing the weak guidance, according to TheFly.<figure class="image"><img style="aspect-ratio:1296/314;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2025_03_06_073150_b10033171b.png" alt="Screenshot 2025-03-06 073150.png" width="1296" height="314"><figcaption>MongoDB retail sentiment and message volume on March 6 as of 7:30 a.m. ET | Source: Stocktwits</figcaption></figure>On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/MDB">MongoDB’s stock</a> surged to ‘extremely bullish’ from ‘neutral’ a day ago, despite Wall Street’s pessimism.Retail chatter jumped to&nbsp;year highs,&nbsp;rising to ‘extremely high’ levels.Some users questioned why MongoDB consistently issues conservative guidance even though its earnings often align with estimates.<stembedurl>https://stocktwits.com/TheVoic/message/606971120</stembedurl>One user speculated that the stock may struggle to recover if the company continues to report negative profit margins and weak guidance each quarter.<stembedurl>https://stocktwits.com/Ranga14r/message/606969034</stembedurl>MongoDB shares have lost nearly 40% over the past year but remain up 12% year-to-date.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/traders-buy-strategy-stock-ahead-michael-saylor-at-trump-white-house-crypto-summit/cheF6mgR6U">Retail Traders Bet Big On Strategy’s Stock Ahead Of Michael Saylor’s Appearance At Trump’s White House Crypto Summit</a> &nbsp;

Mongodb Headquarters (Photo via Smith Collection/Gado/Getty Images).

MongoDB Stock Sinks Pre-Market As Weak Guidance Spawns Downgrade, Price Target Cuts – But Retail Isn’t Worried

Wells Fargo downgraded the stock to ‘Equal Weight’ from ‘Overweight’ and slashed its price target by more than $100 to $225 from $365.

Arm Holdings stock&nbsp;declined over 7%, while shares of Qualcomm rose over 2% after the latter won the legal dispute between the two companies.This marks a 4-month low for Arm, which was last seen trading at these levels in September.Over the weekend, a U.S. federal court sided with Qualcomm after a week-long trial, ruling that its licensing agreement with Arm remained intact despite claims of a breach.&nbsp;The dispute arose after Qualcomm acquired Nuvia, a startup that utilizes Arm's architecture in chip design.&nbsp;Arm alleged that Qualcomm owed higher royalties because Nuvia’s products fell under Qualcomm's umbrella, thus broadening its reliance on Arm’s patents.<figure class="image"><img style="aspect-ratio:1302/289;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_12_23_101118_e1d8a7efde.png" alt="Screenshot 2024-12-23 101118.png" width="1302" height="289"><figcaption>Arm Sentiment and Message Volume on Dec 23 as of 10:05 a.m. ET | Source: Stocktwits</figcaption></figure>On Stocktwits, retail sentiment around Arm remained ‘neutral,’ with chatter increasing to ‘normal’ from ‘low’ levels as users debated whether Qualcomm's partial win had impacted the status quo.&nbsp;<stembedurl>https://stocktwits.com/Vikingmilkman/message/597590709</stembedurl><stembedurl>https://stocktwits.com/jjg111/message/597587654</stembedurl><stembedurl>https://stocktwits.com/Bee4ev/message/597576980</stembedurl>The jury’s decision, however, wasn’t a complete win for Qualcomm. While the court determined no violation of the licensing terms, the jury couldn’t unanimously agree on whether Nuvia had breached its contract with Arm.&nbsp;This leaves room for further legal battles as Arm evaluates its options&nbsp;(suggest attributing this line to some source. Slightly sensitive). But at least for now, Qualcomm is off the hook, lifting retail sentiment.&nbsp;<figure class="image"><img style="aspect-ratio:1290/297;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_12_23_100946_f1fcb2bf39.png" alt="Screenshot 2024-12-23 100946.png" width="1290" height="297"><figcaption>Qualcomm Sentiment and Message Volume on Dec 23 as of 10:05 a.m. ET | Source: Stocktwits</figcaption></figure>While chatter around Qualcomm increased to ‘normal’ from ‘low’ a day ago, sentiment improved to ‘bullish’ from the ‘neutral’ zone.&nbsp;“We are pleased with today’s decision. The jury has vindicated Qualcomm’s right to innovate and affirmed that all the Qualcomm products at issue in the case are protected by Qualcomm’s contract with ARM,” the company said in a statement.“We will continue to develop performance-leading, world class products that benefit consumers worldwide, with our incredible Oryon ARM-compliant custom CPUs,” it added.<a href="https://stocktwits.com/symbol/ARM">Arm Holdings</a> is yet to comment on the verdict.&nbsp;Despite Arm’s dip&nbsp;on Monday, the stock is up over 81% year-to-date, far higher than Qualcomm’s 11% gains&nbsp;in the period.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/arm-stock-slips-as-legal-battle-with-qualcomm-kicks-off-in-delaware/cJaltZYR1L">Arm Stock Slips As Court Room Battle With Qualcomm Kicks Off In Delaware: Retail Divided</a>

POLAND - 2023/09/19: In this photo illustration, the Arm Holdings logo seen displayed on a smartphone with stock market percentages in the background. (Photo Illustration by Omar Marques/SOPA Images/LightRocket via Getty Images)

Arm Stock Slides To 4-Month Low As Qualcomm Jumps On Victory In Licensing Dispute: Retail Remains Unswayed

The jury’s decision, however, wasn’t a complete win for Qualcomm leaving room for further legal battles as Arm evaluates its options.

Super Micro Computer, Inc. ($SMCI) stock pulled back sharply on Tuesday, a day after traders bid up the stock on the relief that the artificial intelligence server maker dodged the delisting bullet, at least for now.At last check, the stock was down 8.26% at $40.51, having traded in the $39.78&nbsp;to&nbsp;$43.35 range.Late Friday,&nbsp;Super Micro&nbsp;confirmed that the Nasdaq granted time until Feb. 25, 2025, to file its&nbsp;annual report on Form 10-K for the fiscal year ending June 30, 2024, and its quarterly report on Form 10-Q for the period ending Sept. 30, 2024.&nbsp;Reacting to the news,&nbsp;the company’s shares rose as much as 9.3% intraday on Monday before giving back most of the gains. At the close, the stock was up 0.52% at $44.16.&nbsp;Tuesday’s weakness comes amid lingering worries about whether Super Micro can meet the late-February deadline and the declines in some AI-levered stocks.Retail, however, is optimistic. A poll run by Stocktwits showed that 84% of the respondents expected Super Micro to file its quarterly report by the Nasdaq-granted deadline.&nbsp;<img src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/smci_poll_9ad2e4c39f.png" alt="smci_poll.png">Among AI news flow, Taiwan Semiconductor Manufacturing Co. Ltd. (<a class="mention" data-mention="$TSM" data-symbol-id="TSM" href="https://stocktwits.com/symbol/TSM" target="_blank">$TSM</a>), the world’s biggest chip supplier, reported a 12% month-over-month drop in November revenue.&nbsp; On a year-over-year basis, revenue was up a solid 34% but the stock slipped over 2%.Shares of enterprise AI software applications company c3.ai, Inc. ($AI) were down about 0.50% after it widened its full-year loss guidance. The 10-Q report filed with the SEC showed CEO Thomas Siebel adopted a plan to sell 12.78 million Class A shares of the company, with the plan set to expire by Dec. 17, 2026.Retail sentiment toward Super&nbsp;Micro’s stock improved from ‘bearish’ a day ago to ‘bullish’ (60/100), with message volume remaining ‘normal.’<figure class="image"><img style="aspect-ratio:642/133;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/smci_sentiment_f6c64ef7ef.png" alt="smci-sentiment.png" width="642" height="133"><figcaption>SMCI sentiment and message volume December 10, 2024, as of 11:33 am ET | Source:&nbsp;Stocktwits</figcaption></figure>A Stocktwits user saw the plunge as normal for volatile stocks, especially after big run-ups.<stembedurl>https://stocktwits.com/Kevothe1/message/595862316</stembedurl>Another said he would use the opportunity to “re-load.”&nbsp;<stembedurl>https://stocktwits.com/postrade/message/595862248</stembedurl>Notwithstanding the stock volatility,&nbsp;Super Micro’s shares are&nbsp;up over 55% for the year, although they are trading&nbsp;well off the March 8 intraday high of $122.90.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Super Micro Computer, Inc. (Supermicro) logo appears on the screen of a smartphone in Reno, United States, on December 7, 2024.

Super Micro’s Volatile Run Continues As Stock Teeters Around $40 Following 9% Drop: Retail Turns Constructive

Tuesday’s weakness comes amid lingering worries about whether Super Micro can meet the late-February deadline and the declines in some AI-levered stocks.

First Trust Exchange-Traded Fund - First Trust NASDAQ-100 Technology Sector Index Fund

Opendoor ($OPEN)

Strategy ($MSTR)

American Eagle ($AEO)

Ondas Inc. ($ONDS)

The stock that proved the power of the crowd. Fueled by community energy and social momentum, this winner captivated retail investors regardless of what the "experts" or traditional fundamentals had to say.

Current Price	$219.78
Prev Close	$219.10
Open	$214.06
Dividend Yield	N/A
50-Day Moving Average	$226.05
Beta	N/A
Avg. Volume	250,550.34
PE Ratio	N/A

52-Week High	$247.98
52-Week Low	$143.80
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A

QTEC
First Trust Exchange-Traded Fund III - First Trust NASDAQ-100 Technology Sector Index Fund

Feed

News

Sentiment

Fundamentals

Info

Latest QTEC News

QTECFirst Trust Exchange-Traded Fund III - First Trust NASDAQ-100 Technology Sector Index Fund